S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
NASDAQ:CLPT

ClearPoint Neuro (CLPT) Stock Price, News & Analysis

$5.81
-0.39 (-6.29%)
(As of 04/12/2024 ET)
Today's Range
$5.72
$6.23
50-Day Range
$5.81
$7.86
52-Week Range
$4.05
$10.95
Volume
194,220 shs
Average Volume
109,811 shs
Market Capitalization
$157.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00

ClearPoint Neuro MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
106.5% Upside
$12.00 Price Target
Short Interest
Healthy
4.73% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.44mentions of ClearPoint Neuro in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.75) to ($0.71) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.22 out of 5 stars

Medical Sector

551st out of 923 stocks

Surgical & Medical Instruments Industry

58th out of 96 stocks

CLPT stock logo

About ClearPoint Neuro Stock (NASDAQ:CLPT)

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

CLPT Stock Price History

CLPT Stock News Headlines

SHOCKING Altcoin Moves…
Bitcoin's recent price boom has sent select altcoins into an absolute FRENZY! Which is why we've gathered 27 crypto experts to share their top picks and predictions as we rapidly approach the Bitcoin halving event this month…
SHOCKING Altcoin Moves…
Bitcoin's recent price boom has sent select altcoins into an absolute FRENZY! Which is why we've gathered 27 crypto experts to share their top picks and predictions as we rapidly approach the Bitcoin halving event this month…
Earnings Outlook For ClearPoint Neuro
The Top 7 Under-$15 Stocks to Buy in March 2024
ClearPoint Neuro, Inc. (CLPT)
ClearPoint Neuro Gets EU OK For 2 Devices
See More Headlines
Receive CLPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ClearPoint Neuro and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/12/2024
Today
4/12/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:CLPT
Employees
107
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.00
High Stock Price Target
$15.00
Low Stock Price Target
$9.00
Potential Upside/Downside
+106.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-22,090,000.00
Pretax Margin
-92.21%

Debt

Sales & Book Value

Annual Sales
$23.96 million
Book Value
$0.86 per share

Miscellaneous

Free Float
25,505,000
Market Cap
$157.28 million
Optionable
Optionable
Beta
0.89
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

CLPT Stock Analysis - Frequently Asked Questions

Should I buy or sell ClearPoint Neuro stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ClearPoint Neuro in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CLPT shares.
View CLPT analyst ratings
or view top-rated stocks.

What is ClearPoint Neuro's stock price target for 2024?

3 Wall Street research analysts have issued 12-month target prices for ClearPoint Neuro's shares. Their CLPT share price targets range from $9.00 to $15.00. On average, they predict the company's share price to reach $12.00 in the next twelve months. This suggests a possible upside of 106.5% from the stock's current price.
View analysts price targets for CLPT
or view top-rated stocks among Wall Street analysts.

How have CLPT shares performed in 2024?

ClearPoint Neuro's stock was trading at $6.79 on January 1st, 2024. Since then, CLPT stock has decreased by 14.4% and is now trading at $5.81.
View the best growth stocks for 2024 here
.

Are investors shorting ClearPoint Neuro?

ClearPoint Neuro saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 1,280,000 shares, a decrease of 8.6% from the March 15th total of 1,400,000 shares. Based on an average daily trading volume, of 152,300 shares, the short-interest ratio is presently 8.4 days.
View ClearPoint Neuro's Short Interest
.

When is ClearPoint Neuro's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our CLPT earnings forecast
.

How were ClearPoint Neuro's earnings last quarter?

ClearPoint Neuro, Inc. (NASDAQ:CLPT) posted its quarterly earnings data on Tuesday, March, 12th. The company reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.03. The firm had revenue of $6.81 million for the quarter, compared to analyst estimates of $6.40 million. ClearPoint Neuro had a negative net margin of 92.21% and a negative trailing twelve-month return on equity of 83.94%.

What guidance has ClearPoint Neuro issued on next quarter's earnings?

ClearPoint Neuro issued an update on its FY 2024 earnings guidance on Tuesday, March, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $28.0 million-$32.0 million, compared to the consensus revenue estimate of $30.4 million.

How do I buy shares of ClearPoint Neuro?

Shares of CLPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CLPT) was last updated on 4/13/2024 by MarketBeat.com Staff

From Our Partners